Compare RGNX & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGNX | KE |
|---|---|---|
| Founded | 2008 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 586.4M |
| IPO Year | 2015 | 2014 |
| Metric | RGNX | KE |
|---|---|---|
| Price | $10.39 | $24.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $28.75 | $28.00 |
| AVG Volume (30 Days) | ★ 2.9M | 215.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | $10,393,000.00 | ★ $1,486,727,000.00 |
| Revenue This Year | $51.21 | N/A |
| Revenue Next Year | $19.08 | $4.57 |
| P/E Ratio | ★ N/A | $30.63 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $18.04 |
| 52 Week High | $16.19 | $33.19 |
| Indicator | RGNX | KE |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 47.46 |
| Support Level | $10.34 | $23.65 |
| Resistance Level | $10.56 | $26.87 |
| Average True Range (ATR) | 1.24 | 1.07 |
| MACD | -0.58 | -0.07 |
| Stochastic Oscillator | 26.14 | 40.87 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.